Login / Signup
Sema3A Inhibits Osteolytic Bone Metastasis of Non-small Cell Lung Cancer.
Wei Wang
Kaicheng Shen
Ruyan Liu
Qi Zhou
Published in:
Recent patents on anti-cancer drug discovery (2024)
This study provides a new idea for the clinical treatment of osteolytic bone metastasis in NSCLC.
Keyphrases
</>
bone mineral density
small cell lung cancer
soft tissue
bone loss
bone regeneration
postmenopausal women
advanced non small cell lung cancer
combination therapy
replacement therapy
tyrosine kinase